Navana Pharma forays into herbal medicine sector with Tk21cr investment | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Tuesday
July 22, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
TUESDAY, JULY 22, 2025
Navana Pharma forays into herbal medicine sector with Tk21cr investment

Stocks

TBS Report
16 January, 2025, 11:30 pm
Last modified: 21 January, 2025, 02:41 pm

Related News

  • Govt mulls OMS sale of potatoes to ensure fair prices for farmers
  • Bodies of 3 killed in Gopalganj exhumed on court orders, sent to hospital morgue
  • Questions raised over training jets flying above crowded city
  • Building bridges: Unlocking the investment potential of Bangladesh’s diaspora
  • Inside the Milestone school plane crash: What kind of aircraft was it?

Navana Pharma forays into herbal medicine sector with Tk21cr investment

The firm plans to establish a dedicated 10,000-square-foot division for manufacturing herbal products, according to a disclosure on the stock exchange’s website on Thursday

TBS Report
16 January, 2025, 11:30 pm
Last modified: 21 January, 2025, 02:41 pm

Infographics: TBS
Infographics: TBS

Navana Pharmaceuticals, a publicly listed company, has decided to venture into the herbal medicine market with a fresh Tk21 crore investment.

The firm plans to establish a dedicated 10,000-square-foot division for manufacturing herbal products, according to a disclosure on the stock exchange's website on Thursday.

The setting up of the herbal division is subject to the approval of concerned regulators. Primarily it needs permission from the Directorate General of Drug Administration (DGDA).

Currently, the pharmaceutical firm operates in both human and animal health medicines, generating approximately 80% of its annual revenue from human health medicines, 17% from veterinary medicines, and 3-4% from exports.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

With the fresh investment through its internal and external sources in the herbal medicines business, the company anticipates additional Tk40 crore revenue in the first year.

The herbal division is set to be completed within five years.

In 2022, Navana Pharmaceuticals raised Tk75 crore from the stock market for expanding its existing businesses, and partial repayment of bank loans.

Lorens Shamol Mollick, company secretary of Navana Pharmaceuticals, told TBS, "The medicine market is growing day by day. Some local big pharma companies are now producing herbal medicines.

"With the seeing good prospects in the future, the company has decided to invest in the herbal medicine segments."

Industry sources said the demand for herbal medicine is growing rapidly due to its lack of side effects and clinical evidence supporting its effectiveness in treating various ailments.

Big pharmaceutical companies in Bangladesh are gradually taking hold of this expanding market as people are opting for higher quality natural remedies with recognisable brand value.

At present, leading drug makers such as Square, Incepta and Acme are catering for herbal medicine.

Although there is no reliable data, the market for herbal medicine generates annual revenue of about Tk2,500 crore.

Navana Pharma financials

According to its annual reports, the revenue of the drugmaker has been growing consistently in the last five years.

From the 2020-21 to 2023-24 fiscal years, its gross revenue grew by 121%, and its net profit by 194%.

In FY24, it had reported a 20% growth in its gross revenue to Tk802.80 crore, and net profit by 13% to Tk40.46 crore.

It had paid a 14% cash dividend only to its general shareholders.

The growth in revenue and profit trajectory has also continued in the first quarter of the current fiscal year.

During the July to September quarter of FY25, its net revenue increased to Tk213.74 crore, and its profit to Tk13.37 crore. In the same period of the previous fiscal year, it was Tk163.15 crore, and Tk11.24 crore respectively. 

Exports on the rise

In FY24, it had reported an 8% growth in its export earnings to Tk25.27 crore.

According to its annual report, in the last five years, its export earnings grew by 67%.

Five years ago in the 2019-20 fiscal year, its export revenue was Tk15.13 crore.

In FY21, its export was Tk24 crore, but it declined to Tk17.64 crore in FY24. Later, its export earnings grew.

Tk11cr IPO fund expected to be used by Sep

In May last year, the drugmaker decided to redirect its initial public offering (IPO) proceeds from modernising and expanding the Small Volume Parenterals and Ophthalmics (SVPO) facility to the construction of a new Generic Production Unit.

In its extraordinary general meeting (EGM), the company also decided to extend the timeline for full utilisation of IPO proceeds to 36 months after receiving the funds, to accommodate the proposed changes in the use of IPO proceeds.

Lorens Shamol Mollick said, "The construction of the new building started before, we are very hopeful to complete using the IPO funds within September this year."

On Thursday, Navana Pharmaceuticals shares price increased by 2.21% to Tk46.20 at the Dhaka Stock Exchange (DSE).

Bangladesh / Top News

Navana Pharma / Bangladesh / investment

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • An ambulance crowded in the aftermath of the plane crash in the capital on 21 July. Photo: Syed Zakir Hossain/TBS
    Wails of despair and pain reverberate at national burn institute
  • The jet plane charred after crash on 21 July at the Milestone school premises. Photo: Mehedi Hasan/TBS
    Apocalypse at school 
  • Photo was taken on 21 July by Syed Zakir Hossain/ TBS
    Govt to bear full treatment costs for Milestone plane crash victims

MOST VIEWED

  • Training aircraft crashes at the Diabari campus of Milestone College on 21 July 2025. Photo: Courtesy
    BAF jet crash at Milestone school: At least 20 including children, pilot dead; 171 hospitalised
  • Flight Lieutenant Md Towkir Islam. Photo: Collected
    Pilot tried to avoid disaster by steering crashing jet away from populated area: ISPR
  • TBS Illustration
    US tariff: Dhaka open to trade concessions but set to reject non-trade conditions
  • 91-day treasury bills rate falls 1.13 percentage points to 10.45% in a week
    91-day treasury bills rate falls 1.13 percentage points to 10.45% in a week
  • An idle luxury: Built at a cost of Tk450 crore, this rest house near Parki Beach in Anwara upazila has stood unused for six months. Perched on the southern bank of the Karnaphuli, the facility now awaits a private lease as the Bridge Division seeks to put it to use. Photo: Md Minhaz Uddin
    Karnaphuli Tunnel’s service area holds tourism promises, but tall order ahead
  • Bangladesh declares one-day state mourning following plane crash on school campus
    Bangladesh declares one-day state mourning following plane crash on school campus

Related News

  • Govt mulls OMS sale of potatoes to ensure fair prices for farmers
  • Bodies of 3 killed in Gopalganj exhumed on court orders, sent to hospital morgue
  • Questions raised over training jets flying above crowded city
  • Building bridges: Unlocking the investment potential of Bangladesh’s diaspora
  • Inside the Milestone school plane crash: What kind of aircraft was it?

Features

Illustration: TBS

Uttara, Jatrabari, Savar and more: The killing fields that ran red with July martyrs’ blood

4h | Panorama
Despite all the adversities, girls from the hill districts are consistently pushing the boundaries to earn repute and make the nation proud. Photos: TBS

Despite poor accommodation, Ghagra’s women footballers bring home laurels

1d | Panorama
Photos: Collected

Water-resistant footwear: A splash of style in every step

1d | Brands
Tottho Apas have been protesting in front of the National Press Club in Dhaka for months, with no headway in sight. Photo: Mehedi Hasan

From empowerment to exclusion: The crisis facing Bangladesh’s Tottho Apas

2d | Panorama

More Videos from TBS

More training plane crashes in Bangladesh

More training plane crashes in Bangladesh

5h | TBS Today
Bird's Eye View of the Sirased Plane Rescue Operation

Bird's Eye View of the Sirased Plane Rescue Operation

6h | TBS Today
How law enforcement is carrying out rescue operations

How law enforcement is carrying out rescue operations

7h | TBS Today
News of The Day, 21 JULY 2025

News of The Day, 21 JULY 2025

7h | TBS News of the day
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net